Kaskela Law Firm Announces Stockholder Investigation of Select Medical Holdings Corporation (NYSE: SEM) and Encourages SEM Shareholders to Contact the Firm
PHILADELPHIA, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Select Medical Holdings Corporation (NYSE: SEM) (“Select Medical”) on behalf of the company’s shareholders.
The investigation seeks to determine whether Select Medical and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions.
Select Medical shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights and options at (484) 229 – 0750. Alternatively, shareholders may contact the firm by email at abell@kaskelalaw.com, or by clicking on the following link (or by copying and pasting the link into your browser):
https://kaskelalaw.com/case/select-medical/
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com
This notice may constitute attorney advertising in certain jurisdictions.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
